About Sialanar® and Prescribing Information

About Sialanar® and Prescribing Information

(320mcg/ml glycopyrronium equivalent to 400mcg/ml glycopyrronium bromide)

Click here for Prescribing Information

Sialanar® received a European Paediatric Use Marketing Authorisation (PUMA) on 15th September 2016 for the symptomatic treatment of severe sialorrhoea (chronic pathological drooling) in children and adolescents aged 3 years and older with chronic neurological disorders

NICE published its latest evidence summary on “Severe sialorrhoea (drooling) in children and young people with chronic neurological disorders: oral glycopyrronium bromide” in February 2017

NICE Evidence Summary


Benefits of Sialanar®

The illustrations below do not represent the colour of Sialanar® or other glycopyrronium solutions

  • Concentrated solution (2mg/5ml glycopyrronium bromide) therefore relatively small volume to swallow
  • Sialanar® has an oral dosing syringe to easily titrate the exact dose based on weight and titration level
  • Raspberry flavouring increases the palatability for the patient
  • Sialanar® requires no further manipulation and is licensed to be administered via feeding tubes
  • Sugar-free solution with minimal excipients

Product Sialanar®
Mode of action Antichollingeric
Composition 320mcg/ml glycopyrronium equivalent to 400mcg/ml glycopyrronium bromide
Pack Sizes 250ml or 60ml amber glass bottle (includes one 8 ml low density polyethylene oral syringe and one syringe adaptor)
Appearance Clear and colourless
Flavour Raspberry
Viscosity Aqueous solution
Sweetener Sucralose (E955)
Lactose-free Yes
Carbohydrate free Yes
Gluten-free Yes
Storage conditions Do not store above 25°C
Suitable for feeding tubes Yes – suitable for GJ, PEG and Nasogastric
Sodium Free Yes
Sortbitol Free Yes
Fructose free Yes
Aspartame Free Yes
Tartrazine Free Yes
Shelf Life unopened 2 years
Shelf life once opened 2 months

Please refer to SMPC for dosing information.


Created May 2020